Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: GMED

Globus Medical, Inc.

Healthcare | Medical - Devices

No licensed closing price on file for GMED. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$3.89

Globus Medical, Inc. (NYSE: GMED) is a medical device company. Figures from SEC EDGAR; updated 2026-10-20 06:02 UTC.

What Globus Medical, Inc. does

The company manufactures medical devices that must obtain regulatory clearance from the FDA and other authorities before being marketed. Most of the company's currently commercialized products have received clearance under the 510(k) process or are exempt from review, though some products obtained approval through alternative pathways including PMA and HDE processes. The FDA clearance processes vary in cost and timeline, with 510(k) clearance typically taking several months and PMA approval taking considerably longer and being more expensive.

Summarized from Globus Medical, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (TTM)$3.89
Return on equity11.76%

Revenue, margins & earnings

FY2021 Net income: $149MFY2021 Taxes & interest: $23MFY2021 Operating costs: $786M$958MFY2021FY2022 Net income: $190MFY2022 Taxes & interest: $38MFY2022 Operating costs: $795M$1.02BFY2022FY2023 Net income: $123MFY2023 Operating costs: $1.44B$1.57BFY2023FY2024 Net income: $103MFY2024 Taxes & interest: $63MFY2024 Operating costs: $2.35B$2.52BFY2024FY2025 Revenue: $2.94B — margin split not shown (non-operating gains)$2.94BFY2025
  • Net income
  • Taxes & interest
  • Operating costs
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-16
  • 2026-09-16DirectorOption exercise15,000$806.2K
  • 2026-09-16DirectorStock Option (Right to Buy Class A Common Stock)Option exercise-15,000—
  • 2026-09-16DirectorSale-30,000$2.24M
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Globus Medical, Inc. do?

The company manufactures medical devices that must obtain regulatory clearance from the FDA and other authorities before being marketed.

When did GMED last file with the SEC?

Globus Medical, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-04. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 06:02 UTC. This page is also available as JSON at /api/data?ticker=GMED and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for GMED and 5,000+ tickers.

Create a free account — keep GMED
For your agent
GET /api/data?ticker=GMED

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt